VIDEO: Congressman Moran Warns of China’s Aggressive Push to Dominate Pharmaceuticals and Biotechnology

During a hearing of the House Select Committee on the Chinese Communist Party this week, U.S. Rep. Nathaniel Moran (TX-01) highlighted China’s aggressive efforts to dominate the pharmaceutical and biotechnology sectors and stressed the need for the United States to maintain its edge in medical innovation and supply chain security.

“The United States has historically led the world in medical innovation, and that leadership did not happen by accident,” Moran said. “It grew from a culture that values scientific inquiry, protects intellectual property, and respects the dignity of every patient who participates in research. But the global landscape has changed quickly.

“China has made biotechnology and pharmaceuticals a national priority, with a clear goal: to compete with and ultimately surpass American firms,” Moran continued.

“Today, for certain essential generic medicines, China is already the dominant, or even sole, producer of key active pharmaceutical ingredients. That is why American leadership in emerging pharmaceutical technologies is so critical. Innovation is America’s strength. It always has been, and we must ensure the United States continues to lead.”

https://www.youtube.com/watch?v=PWU0zONYwR4